Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marie-Claude Laliberté"'
Autor:
Stephanie G. Werner, Xenofon Baraliakos, Sabine Reckert, Martin Bohl-Bühler, Marie-Claude Laliberté, Tanya Girard, Katharina Jeromin, Nikola Baschuk, Björn Fritz, Louis Bessette, Axel J. Hueber
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1503-1518 (2023)
Abstract Introduction Our aim was to investigate the efficacy and safety of upadacitinib (UPA) in patients with either oligo- or polyarticular active psoriatic arthritis (PsA) using routine clinical practice data from an observational, prospective, m
Externí odkaz:
https://doaj.org/article/a787fb929fe14fb9989f5c14f59ca8bb
Autor:
Krishna Donepudi, Tania Gaetano, Martin G. Latour, Katia Charland, Brad Millson, Kevin McHugh, Sandra Gazel, John Marshall, Marie-Claude Laliberté, Neeraj Narula
Publikováno v:
Journal of the Canadian Association of Gastroenterology
Background Adalimumab is an antitumour necrosis factor (TNFα) biologic therapy indicated for the treatment of Crohn’s disease (CD). Patients receiving adalimumab in Canada are eligible to enroll in the AbbVie Care™ patient support program (AC-PS
Autor:
Marie-Claude Laliberté, Sandra Gazel, Gerald Lebovic, Martin G. Latour, Louis Bessette, Neil H. Shear, Brad Millson, J. Carter Thorne, Tania Gaetano, Jennifer Glass, John Marshall
Publikováno v:
Clinical Therapeutics. 40:1024-1032
The aim of this study was to quantify the association between receiving care-coach calls (CCCs), a service provided by a patient-support program (PSP) in Canada, and persistence with and adherence to adalimumab therapy over a 3-year period in patient
Autor:
Sandra Gazel, Carter Thorne, Martin G. Latour, V. Remple, Marie-Claude Laliberté, Krishna Donepudi, Tania Gaetano, Gerald Lebovic, Louis Bessette, Katia Charland, Brad Millson
Publikováno v:
Rheumatology and Therapy. 5:75-85
Adalimumab (ADA) is a tumor necrosis factor (TNF)-alpha inhibitor indicated for the treatment of inflammatory autoimmune diseases, including ankylosing spondylitis (AS). Patients receiving ADA in Canada are eligible to enroll in the AbbVie Care™ pa
Publikováno v:
Osteoporosis International. 24:1803-1815
In a mailed survey and qualitative interviews, it was observed that community pharmacists and public health authorities believe that pharmacists should play a significant role in the prevention and management of osteoporosis and the risk of falls. Ho
Autor:
Sebastien K. Gerega, Louis Bessette, Driss Oraichi, Gerald Lebovic, Brad Millson, Martin G. Latour, Neil H. Shear, Marie-Claude Laliberté, Sandra Gazel, Tania Gaetano, John Marshall, Carter Thorne
Publikováno v:
Clinical Therapeutics. 40:415-429.e6
Adalimumab (ADA) is a tumor necrosis factor-α inhibitor indicated for use in various immune-mediated inflammatory diseases. Patients receiving ADA in Canada are eligible to enroll in the AbbVie Care's Patient Support Program (PSP), which provides pe
Autor:
Lyne Lalonde, Isabel Rodrigues, D. Corbeil, Sylvie Perreault, Lucie Blais, Marie-Claude Laliberté, Alice Dragomir, Johanne Goudreau, Nicole Damestoy
Publikováno v:
Osteoporosis International. 21:1471-1485
Attendance at a fragility-fractures-prevention workshop by primary care physicians was associated with higher rates of osteoporosis screening and treatment initiation in elderly female patients and higher rates of treatment initiation in high-risk ma
Autor:
Sylvie Perreault, Manon Choinière, Anaïs Lacasse, Danielle Bélanger, Lise Lévesque, Eveline Hudon, Marie-Claude Laliberté, Élisabeth Martin, Lyne Lalonde
Publikováno v:
Journal of Pain Research
Lyne Lalonde,1–4 Manon Choinière,3,5 Elisabeth Martin,3 Lise Lévesque,3 Éveline Hudon,2,3,6 Danielle Bélanger,2 Sylvie Perreault,1,7 Anaïs Lacasse,8 Marie-Claude Laliberté1,9 1Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canad
Publikováno v:
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. 146(1)
Background: Practice-based research networks (PBRNs) are groups of practitioners and researchers with an interest in designing, evaluating and disseminating solutions to the real-world problems of clinical practices. Objective: To evaluate the level
Autor:
Gerald Lebovic, Driss Oraichi, John Marshall, Sandra Gazel, Marie-Claude Laliberté, Louis Bessette, Martin G. Latour, Brad Millson, Sebastien K. Gerega, Michael Sung, Tania Gaetano
Publikováno v:
American Journal of Gastroenterology. 111:S446